Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Netflix, Inc. (NFLX): Next Stop $205?

Page 1 of 2

The ceiling is getting higher at Netflix, Inc. (NASDAQ:NFLX) .

JPMorgan analyst Doug Anmuth is bumping his price target on shares of the leading video service provider from $180 to $205.

With the shares closing at $177.95 yesterday, it just didn’t seem right to be bullish with a price goal calling for just 1% in capital appreciation. However, Anmuth relays that recent meetings with the company indicate that “House of Cards” is off to a strong start. He feels that the show’s success will find Netflix digging deeper to bankroll original programming.

Netflix, Inc. (NASDAQ:NFLX)We already got a taste of that yesterday when Netflix broadened its deal with Dreamworks Animation Skg Inc (NASDAQ:DWA) to be the exclusive home of a new computer animated series that will begin streaming by year’s end.

Netflix now has a half dozen shows that will stream exclusively through its service this year. Netflix has always wanted to be compared to Time Warner Inc. (NYSE:TWX)‘s HBO. It has surpassed HBO with more than 33 million streaming subscribers, and with a few strokes of contract signatures, it’s now the undeniable home of “must-stream” television.

Spacey sprockets
How successful is “House of Cards,” exactly? Netflix isn’t putting out any firm numbers — yet — but content chief Ted Sarandos did provide some insight at AllThingsD’s D: Dive Into Media yesterday.

It’s probably not a surprise to find that the show is the service’s top piece of content right now in terms of the number of people watching and the hours being streamed. The initial 13-episode season became available in its entirety this month, and since it can only be seen via Netflix’s $7.99-a-month streaming service, the star-studded political drama is going to be a big draw.

However, Sarandos did say that nearly everybody who’s watched the first episode has gone on to stream subsequent installments. That’s encouraging. It validates the controversial “binge viewing” approach, where Netflix makes an entire season’s worth of episodes available immediately. It also makes it more likely that those subscribers will stick around for the next season come early next year.

Binge and purge
“We are crafting long-form story telling for any way you want to watch,” Sarandos says, as retold by CNET. “We won’t get the weekly buzz thing, but neither do albums … or books.”

He’s right about albums and books, but when was the last time folks around the water cooler discussed an album and book and revisited the same topic week after week with new details to add?

Folks are definitely smitten by the show. I’m six episodes in, and I’m mesmerized. However, I can’t simply begin buzzing about the show with others watching along. No one is on the same page. There will never be a who-shot-JR “Dallas” moment here, where everyone’s glued to the same cliffhanger. Maybe that’s OK. There really haven’t been too many of those moments for scripted television these days, anyway. There are too many channels and streaming options, so everyone is watching something else.

Blame it on TiVo Inc. (NASDAQ:TIVO)
TiVo opened this can of worms. Sure, VHS recorders came before it, but TiVo’s internal storage and intuitive controls — and, of course, the benefit of time-shifting live content — made it a radical upgrade to the way we were consuming television before.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!